Metraipolis › archive › dc_3129e01863cf

Optimizing clarification processes in biopharmaceutical manufacturing through quality by design: Strategies, implications, and future prospects — Europe PMC PMID:40810245

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40810245
DOI
10.1002/btpr.70063
License (as archived)
solo-consultazione
Archived
2026-11-10T15:57:10.629Z
SHA-256 of the archived text
8d440b9dc1e2039806f400f3fadca22840bb2ff614adcd7309a7577cc4642abd
Stable URL of this page
https://metraipolis.com/documento/dc_3129e01863cf

How to cite

Optimizing clarification processes in biopharmaceutical manufacturing through quality by design: Strategies, implications, and future prospects — Europe PMC PMID:40810245 — Europe PMC (en), https://europepmc.org/article/MED/40810245 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3129e01863cf (Metraipolis archive dc_3129e01863cf, sha256 8d440b9dc1e2039806f400f3fadca22840bb2ff614adcd7309a7577cc4642abd)
BibTeX
@misc{dc3129e01863cf,
  title = {Optimizing clarification processes in biopharmaceutical manufacturing through quality by design: Strategies, implications, and future prospects — Europe PMC PMID:40810245},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40810245},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3129e01863cf; sha256 8d440b9dc1e2039806f400f3fadca22840bb2ff614adcd7309a7577cc4642abd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40810245. Agents can read the archived copy with the MCP tool read_document.